Severe Asthma and Biological Therapies: Now and the Future

Severe Asthma and Biological Therapies: Now and the Future

Recognition of phenotypic variability in pediatric asthma allows for a more personalized therapeutic approach. Knowledge of the underlying pathophysiological and molecular mechanisms (endotypes) of corresponding biomarkers and new treatments enables this strategy to progress. Biologic therapies for...

Full description

Bibliographic Details
Main Authors: Olaia Sardon-Prado, Carolina Diaz-Garcia, Paula Corcuera-Elosegui, Javier Korta-Murua, Jose Valverde-Molina, Manuel Sanchez-Solis
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Journal of Clinical Medicine
Subjects:
severe asthma
biologic
phenotype
biomarkers
omalizumab
mepolizumab
Online Access:https://www.mdpi.com/2077-0383/12/18/5846

Internet

https://www.mdpi.com/2077-0383/12/18/5846

Similar Items